What is Insmed's revenue?

Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.

Is Insmed profitable?

Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.

What are Insmed's profit margins?

Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.

What is Insmed's earnings per share?

Insmed's diluted EPS over the trailing twelve months is $-5.74.

Where does Insmed's income statement data come from?

Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Insmed INSM Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$819.56M+115%	$606.42M+66.7%	$447.02M+30.3%	$398.11M+21.2%	$381.03M+20.8%
Total cost of revenue	$149.08M+66.5%	$122.94M+43.4%	$104.87M+34.4%	$96.67M+31.4%	$89.56M+29.4%
Research and development	$828M+31.5%	$771.09M+28.9%	$695.91M+25.2%	$660.3M+28.5%	$629.86M+11.6%
Selling, general and administrative	$800.88M+55.3%	$701.17M+52.1%	$631.2M+56.0%	$563.75M+51.6%	$515.56M+46.7%
Compensation and benefits	$159.2M+38.9%	$152.71M+57.7%	$140.23M+55.3%	$134.34M+58.6%	$114.65M+43.7%
Occupancy and equipment	$13.6M+10.6%	$13.6M+14.3%	$13.3M+18.8%	$12.8M+18.5%	$12.3M+21.8%
Depreciation and amortization	$6.82M+35.0%	$6M+18.8%	$5.33M-3.1%	$5.05M-8.1%	$5.05M-8.1%
Goodwill impairment	——	——	——	——	——
Other operating expenses	——	——	——	——	——
Total costs & expenses	$1.97B+44.8%	$1.85B+49.2%	$1.6B+37.2%	$1.4B+28.8%	$1.36B+33.2%
Operating income	-$1.15B-17.4%	-$1.25B-42.0%	-$1.16B-40.1%	-$1B-32.2%	-$980.89M-38.7%
Operating margin	-140.6%+117pp	-205.6%+35.9pp	-258.9%-18.0pp	-252.4%-21.0pp	-257.4%-33.3pp
Interest expense	$82.31M-3.7%	$83.8M-1.3%	$84.75M+0.7%	$85.42M+2.4%	$85.44M+3.3%
Other income (expense), net	-$2.71M—	-$1.84M—	——	——	——
Income before income taxes	-$1.18B-16.7%	-$1.27B-39.7%	-$1.18B-37.0%	-$1.03B-28.8%	-$1.01B-35.6%
Income tax expense	$5.58M+38.4%	$5.03M+35.6%	$4.74M+37.9%	$4.44M+49.4%	$4.03M+51.4%
Net income	-$1.18B-16.8%	-$1.28B-39.7%	-$1.18B-37.0%	-$1.03B-28.9%	-$1.01B-35.7%
Net margin	-144.4%+121pp	-210.5%+40.7pp	-264.8%-12.8pp	-259.8%-15.5pp	-265.9%-29.2pp
Diluted earnings per share	-$5.74+3.2%	-$6.40-14.9%	-$6.17-11.2%	-$5.69-5.6%	-$5.93-13.4%
Basic earnings per share	-$5.74+3.2%	-$6.40-14.9%	-$6.17-11.2%	-$5.69-5.6%	-$5.93-13.4%
Weighted-average shares, diluted	815.5M+21.1%	780.9M+21.8%	746M+20.8%	707.9M+20.7%	673.3M+18.3%
Weighted-average shares, basic	815.5M+21.1%	780.9M+21.8%	746M+20.8%	707.9M+20.7%	673.3M+18.3%
Accretion Of Debt Discount, Marketable Securities	$36.53M+43.1%	$38.35M+100%	$38.98M+247%	$33.11M+192%	$25.53M+125%
Share-based compensation expense related to employee stock plans	$159.2M+38.9%	$152.71M+57.7%	$140.23M+55.3%	$134.34M+58.6%	$114.65M+43.7%
Amortization Of Financing Costs And Discounts	$5.78M-15.7%	$6.22M-9.7%	$6.59M-4.4%	$6.73M-7.1%	$6.86M-7.9%
Amortization of capitalized software and acquired intangible assets	$6.82M+35.0%	$6M+18.8%	$5.33M+5.4%	$5.05M0.0%	$5.05M0.0%
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1	$186.73M—	$251.99M—	——	——	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	——	——	-$126.69M-394%	$37.53M-94.1%	-$192.48M+48.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$1.18B-16.8%	-$1.27B-39.1%	-$1.18B-37.2%	-$1.03B-28.0%	-$1.01B-35.1%
Contract With Customer, Asset, Allowance For Current Period Sales	——	$135.58M+144%	$115.55M+117%	$95.53M+87.7%	$75.51M+55.3%
Allowances for prior period sales	——	$500K-85.6%	$1.25M-51.8%	$1.99M+18.4%	$2.74M+250%
Contract With Customer, Assets, Allowance For Credit Loss, Payments and Credits	——	$78.98M+26.6%	$74.83M+31.6%	$70.68M+37.6%	$66.52M+45.1%
Federal	——	$0—	$0—	$0—	$0—
Foreign	——	$4.48M+32.4%	$4.2M+35.9%	$3.93M+40.0%	$3.65M+45.1%
Current State And Local Tax Expense Benefit	——	$577K+62.1%	$521.75K+44.3%	$466.5K+27.1%	$411.25K+10.4%
Federal	——	$0—	$0+100%	$0+100%	$0+100%
Deferred Foreign Income Tax Expense Benefit	——	$0—	$0—	$0—	$0—
Deferred taxes	-$27K+6.9%	-$27K+6.9%	-$29K+46.3%	-$29K+46.3%	-$29K+46.3%
State	——	-$27K+6.9%	-$27.5K+14.1%	-$28K+20.0%	-$28.5K+25.0%
Defined contribution plan costs	——	$12.8M+73.0%	$11.45M+65.3%	$10.1M+56.6%	$8.75M+46.4%
Defined Contribution Plan Employer Matching Contribution Percent	——	——	——	——	——
Defined Contribution Plan Employer Matching Contribution Percent Of Match	——	——	——	——	——
Depreciation	$11.5M+83.8%	$10.45M+75.3%	$8.3M+39.4%	$7.3M+21.9%	$6.26M+6.6%
Effect of exchange rate changes on cash, cash equivalents and restricted cash	——	——	——	$2.23M—	$541K—
Effective tax rates	——	-$0+25.0%	-$00.0%	-$0-40.0%	-$0-114%
Asset acquisition	——	——	——	——	——
Change in fair value of contingent consideration	——	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——	——
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate	——	——	——	——	——
Effect of cross-border tax laws	——	$0—	$0—	$0—	$0—
Effect of cross-border tax laws	——	——	——	——	——
Other	——	-$0—	-$0-200%	-$00.0%	-$0+66.7%
Asset acquisition	——	$0—	$0-100%	$0-100%	$0-100%
Change in fair value of contingent consideration	——	$52.92M+175%	$44.5M+179%	$36.09M+186%	$27.67M+196%
Share-based compensation	——	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——	——
Effective Income Tax Rate Reconciliation Tax Credits Research	——	——	——	——	——
Finance Lease Principal Payments	$3.05M+13.3%	$2.96M+13.4%	$2.87M—	$2.78M—	$2.7M—
Acquired intangibles	$45M—	$45M—	$30M—	$0—	$0—
Goodwill impairment losses	——	——	——	——	——
Impairment of intangible assets	——	$0—	$0—	$0—	$0—
Income Loss From Continuing Operations Before Income Taxes Domestic	——	-$1.12B-37.3%	-$1.04B-34.1%	-$966.51M-30.5%	-$890.52M-26.6%
Income Loss From Continuing Operations Before Income Taxes Foreign	——	-$153.26M-60.4%	-$138.83M-51.1%	-$124.4M-41.1%	-$109.97M-30.1%
Federal taxes	——	$0—	$0—	$0—	$0—
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount	——	$271.34M+46.4%	$249.84M+45.4%	$228.35M+44.3%	$206.86M+43.0%
Income Tax Reconciliation Change In Enacted Tax Rate	——	$0—	$0—	$0—	$0—
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	——	-$267.07M-39.7%	-$248.08M-35.9%	-$229.09M-31.7%	-$210.1M-27.0%
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	——	$729K+136%	$624K+39.3%	$519K-11.6%	$414K-43.0%
Share-based compensation	——	-$59.41M-372%	-$47.7M-441%	-$35.99M-611%	-$24.28M-1,752%
Effective Income Tax Rate Reconciliation, Other Adjustments, Amount	——	$8.18M-14.5%	$8.53M+3.5%	$8.87M+28.5%	$9.22M+65.3%
Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount	——	$552K+72.0%	$494.25K+52.0%	$436.5K+32.5%	$378.75K+13.5%
Changes in unrecognized tax benefits	——	$0—	$0—	$0—	$0—
Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount	——	$38.87M+26.0%	$36.87M+28.3%	$34.87M+31.1%	$32.86M+34.3%
Income Taxes Paid, Net	$4.91M+41.5%	$4.14M+65.7%	$4.28M+83.9%	$3.79M+75.9%	$3.47M+60.6%
Accounts payable and other current liabilities	$127.69M+727%	$100.07M+124%	$50.86M+102%	$6.02M-65.9%	$15.45M+285%
Increase (Decrease) in Accounts Receivable	$131.86M+1,153%	$88.31M+583%	$22.82M+304%	$12.63M+17.5%	$10.53M+29.2%
Increase (Decrease) in Inventories	$32.38M+85.4%	$31.52M+84.9%	$21.88M+13.0%	$14.69M+5.8%	$17.47M+34.1%
Increase (decrease) in other assets	$14.65M—	$2.12M—	-$12.37M—	——	——
Other liabilities	-$3.32M+58.3%	-$4.99M+58.2%	-$8.66M+32.0%	-$8.18M+35.0%	-$7.97M+49.3%
Increase (Decrease) in Prepaid Expense and Other Assets	$23.9M—	$53.43M—	——	——	——
Incremental Common Shares Attributable To Conversion Of Debt Securities	0—	0—	0—	0—	0—
Interest Expense, Excluding Finance Lease Interest Expense	$80.36M-3.5%	$81.79M-1.1%	$82.68M+1.0%	$83.3M+2.8%	$83.26M+3.6%
Swap interest income	——	$0+100%	-$557.25K+74.0%	-$1.11M+45.8%	-$1.67M+15.1%
Interest Paid, Excluding Capitalized Interest, Operating Activity	$55.35M+21.7%	$55.35M+36.4%	$57.08M+69.6%	$50.26M+52.4%	$45.48M+40.3%
Investment and other (expense) income, net	$58.79M+0.6%	$60.66M+13.8%	$62.68M+36.5%	$61.37M+55.4%	$58.43M+44.7%
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$954.59M-30.2%	$954.07M-28.9%	$1.08B-17.3%	$1.44B+58.8%	$1.37B+695%
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	——	——	——	——	——
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	-$895.66M-17.6%	-$935.01M-36.7%	-$883.4M-42.8%	-$844.55M-47.1%	-$761.94M-32.7%
Non-cash operating lease expense	$9.53M—	$9.65M—	$4.11M—	$3.55M—	——
Number of operating segments	1.8—	1—	——	——	——
Number of reportable segments	——	——	——	——	1.8+75.0%
Net unrealized debt securities gains (losses), net of tax	$113K—	$461K—	——	——	——
Foreign currency translation	——	——	$1.15M—	$4.68M—	$828K—
Other comprehensive income/(loss)	——	——	$1.45M—	$4.56M—	$734K—
Other Noncash Expense	$20.77M+2.6%	$20.68M+3.1%	$20.41M+3.0%	$20.54M-16.9%	$20.25M-3.8%
Other income, net (Note 6)	-$2.71M—	-$1.84M—	——	——	——
Payment Of Milestone	——	——	——	——	$0—
Payments to Acquire Marketable Securities	$1.46B-33.8%	$2.09B+32.6%	$2.67B+106%	$2.48B+739%	$2.21B+275%
Payments to Acquire Property, Plant, and Equipment	$25.97M-4.9%	$32.56M+48.5%	$22.74M+31.4%	$24.02M+45.8%	$27.31M+87.5%
Proceeds From Issuance Of Secured Debt	——	$0-100%	$37.5M-66.7%	$75M0.0%	$112.5M+200%
Proceeds from maturities of marketable securities	$1.65B—	$2.09B—	$2.37B—	——	——
Cash received from option exercises	$136.33M-1.8%	$135.72M+19.8%	$114.82M+7.2%	$107.29M+29.9%	$138.9M+552%
Revenue From Contract With Customer Excluding Assessed Tax	$819.56M+115%	$606.42M+66.7%	$447.02M+30.3%	$398.11M+21.2%	$381.03M+20.8%
Stock-based compensation	$159.2M+38.9%	$152.71M+57.7%	$140.23M+55.3%	$134.34M+58.6%	$114.65M+43.7%
Inducement stock options granted to new employees (in shares)	——	——	——	——	——
Inducement total authorized for grant (in shares)	——	——	——	——	——
Inducement stock option granted to new employees (in shares)	——	——	——	——	——
Contingent payments for Business Acquisition	$91.43M—	$48.75M—	——	——	——
Stock Issued During Period, Value, Conversion of Convertible Securities	——	——	——	$790.47M—	——
Stock Issued During Period, Value, Stock Options Exercised	$136.29M-1.9%	$135.73M+19.9%	$114.83M+7.1%	$107.3M+29.9%	$138.9M+552%
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	——	$5.65M+32.6%	$5.3M+34.5%	$4.96M+36.8%	$4.61M+39.5%
Additions for tax positions of prior years	——	$0—	$0-100%	$0-100%	$0-100%
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	——	$331.4M+49.8%	$303.88M+141%	$276.35M+786%	$248.83M+490%
Variable Lease Cost	$29.86M+27.5%	$24.76M-4.1%	$26.62M+0.6%	$23.62M+30.9%	$23.42M+23.6%
EBIT	-$1.15B-17.4%	-$1.25B-42.0%	-$1.16B-40.1%	-$1B-32.2%	-$980.89M-38.7%
EBITDA	-$1.13B-16.9%	-$1.23B-41.9%	-$1.14B-40.1%	-$992.5M-32.0%	-$969.58M-38.5%
EBITDA	-$1.13B-16.9%	-$1.23B-41.9%	-$1.14B-40.1%	-$992.5M-32.0%	-$969.58M-38.5%
EBITDA margin	-138.3%+116pp	-202.9%+35.6pp	-255.9%-17.8pp	-249.3%-20.4pp	-254.5%-32.6pp
EBIT	-$1.15B-17.4%	-$1.25B-42.0%	-$1.16B-40.1%	-$1B-32.2%	-$980.89M-38.7%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Insmed.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Insmed's revenue?: Insmed (INSM) generated $819.6M in revenue over the trailing twelve months, up 115.1% year over year.
Is Insmed profitable?: Insmed is not currently profitable: it reported a net loss of $1.2B over the trailing twelve months, a -144.4% net margin.
What are Insmed's profit margins?: Gross margin is 81.8% and operating margin is -140.6%, with a -144.4% net margin.
What is Insmed's earnings per share?: Insmed's diluted EPS over the trailing twelve months is $-5.74.
Where does Insmed's income statement data come from?: Every line is extracted from Insmed's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.